The EU Home Affairs Sub-Committee takes evidence on reciprocal healthcare after Brexit. The two evidence sessions will cover the reciprocal healthcare implications of Brexit for UK citizens travelling, living and/or working in the rest of the EU, and for EU citizens travelling, living and/or working in the UK, in both the short and medium term.
Wednesday 11 October, Committee Room 3, Palace of Westminster
- Professor Jean McHale, Professor of Healthcare Law, Director of the Centre for Health Law Science and Policy, University of Birmingham
- Professor Catherine Barnard, Professor of EU law, University of Cambridge and associate fellow, UK in a Changing Europe
- Laura Brackwell, Director, National Audit Office
- David Raraty, Audit Manager, National Audit Office
- Bob Alexander, Deputy Chief Executive, NHS Improvement
- Can you give a brief overview of the research methodology and key findings of the report? What areas of NHS treatment does it cover?
- In the event that there is no deal in place between the UK and EU on the day that the UK is no longer a member of the EU, what will be the default position as a matter of law for healthcare coverage for UK citizens in the EU and vice versa?
- As a general picture, would we be right to conclude that the difference between what is potentially chargeable and what is actually charged is much greater for EEA nationals than non-EEA nationals? Can you explain why this might be the case?
- What process do trusts use to identify patients who are covered by EEA schemes, and to identify patients whose access to treatment is chargeable?